|
Staff presence and dynamics (35)
|
|
Dedicated team/staff (11)
|
"Accrual has proven to be most successful when a CRA/Research Nurse has been highly involved."
|
|
Staff awareness of CCL studies (9)
|
"Awareness (includes CRAs, staff physicians, nurses, fellows) - we feel that very few individuals are aware of these studies." "Weekly COG meetings with research nurse, CRAs and PI; we all know where studies stand, cuts down on emails between each other; helps prioritize studies."
|
|
Team communication (6)
|
"A more clear system of communication when potential patients are identified."
|
|
"It's basically a team approach."
|
|
Physician consent/support (6)
|
"Having a physician's support in identifying and consenting patients is a very important component for accrual."
|
|
Presence of a CCL champion (3)
|
"If we have a specific person who is "championing" the protocol we have more accrual to the protocol."
|
|
Logistics including adequate numbers of eligible patients (7)
|
|
Ability to identify eligible patients (4)
|
"Part of successful accrual is being organized in tracking and approaching all eligible patients."
|
|
Eligible/willing patients (2)
|
"Patient willingness."
|
|
Timing of approach (1)
|
"Timing of consent discussion (not at diagnosis as families are overwhelmed with information)."
|
|
Interests and priorities (11)
|
|
Patient potential benefit (4)
|
"Protocols that have potential patient benefit or have therapeutic intent (ACCL0933) are prioritized over other CCL studies."
|
|
Division/department interest/support (3)
|
"Our institutional stance is that CCL trials need to be broadly supported and embraced by the COG voting body,"
|
|
Prioritization of CCL studies at institution (2)
|
"Our division as a whole being interested and supportive of COG studies,"
|
|
No competing treatments (2)
|
"If [competing treatments] were to open that could affect the accrual rate for the CCL studies."
|
|
Resources (5)
|
|
Funding and resources (5)
|
"CCL trials need to be (…) supported with adequate funding."
|
